Audrey E. Kam

581 total citations
17 papers, 247 citations indexed

About

Audrey E. Kam is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Audrey E. Kam has authored 17 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Audrey E. Kam's work include Cancer Immunotherapy and Biomarkers (8 papers), Prostate Cancer Treatment and Research (7 papers) and Cancer Genomics and Diagnostics (4 papers). Audrey E. Kam is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Prostate Cancer Treatment and Research (7 papers) and Cancer Genomics and Diagnostics (4 papers). Audrey E. Kam collaborates with scholars based in United States, United Kingdom and Australia. Audrey E. Kam's co-authors include Ashiq Masood, Rachna T. Shroff, Margitta Retz, Sam G. Pappas, Evan Y. Yu, Brigitte Laguerre, Johann S. de Bono, Gwénaëlle Gravis, Peter C.C. Fong and Howard Gurney and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Audrey E. Kam

17 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey E. Kam United States 7 161 102 93 70 64 17 247
Seung Tae Kim South Korea 9 186 1.2× 169 1.7× 89 1.0× 62 0.9× 67 1.0× 16 322
L. Cannella Italy 9 143 0.9× 69 0.7× 77 0.8× 46 0.7× 70 1.1× 26 276
Markus Moehler Germany 9 207 1.3× 175 1.7× 126 1.4× 41 0.6× 55 0.9× 24 320
Jiaoyue Jin China 9 202 1.3× 84 0.8× 113 1.2× 62 0.9× 59 0.9× 21 298
Xiaobo Bo China 11 124 0.8× 99 1.0× 138 1.5× 80 1.1× 88 1.4× 24 278
Leonie K. de Klerk Netherlands 4 119 0.7× 87 0.9× 58 0.6× 41 0.6× 59 0.9× 4 219
Arnab Basu United States 9 165 1.0× 126 1.2× 87 0.9× 58 0.8× 62 1.0× 49 284
Yunjian Huang China 9 217 1.3× 182 1.8× 69 0.7× 73 1.0× 65 1.0× 30 345
Juan Ruiz‐Bañobre Spain 10 189 1.2× 95 0.9× 44 0.5× 56 0.8× 76 1.2× 22 284
Sejung Park South Korea 10 155 1.0× 151 1.5× 120 1.3× 32 0.5× 44 0.7× 22 274

Countries citing papers authored by Audrey E. Kam

Since Specialization
Citations

This map shows the geographic impact of Audrey E. Kam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey E. Kam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey E. Kam more than expected).

Fields of papers citing papers by Audrey E. Kam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey E. Kam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey E. Kam. The network helps show where Audrey E. Kam may publish in the future.

Co-authorship network of co-authors of Audrey E. Kam

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey E. Kam. A scholar is included among the top collaborators of Audrey E. Kam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey E. Kam. Audrey E. Kam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kam, Audrey E., et al.. (2022). S1502 Effect of Immunotherapy in Gastrointestinal Cancers Based on Time of Treatment. The American Journal of Gastroenterology. 117(10S). e1076–e1077. 1 indexed citations
2.
Kam, Audrey E., Ashiq Masood, & Rachna T. Shroff. (2021). Current and emerging therapies for advanced biliary tract cancers. ˜The œLancet. Gastroenterology & hepatology. 6(11). 956–969. 102 indexed citations
3.
Kam, Audrey E. & Ashiq Masood. (2021). The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions. Annals of Surgical Oncology. 28(6). 2939–2940. 3 indexed citations
4.
Kam, Audrey E., Ateeq Khaliq, Dana M. Hayden, et al.. (2021). Targeted multiplex proteomics (TMP) and genomics of early-onset colorectal cancer (EO-CRC).. Journal of Clinical Oncology. 39(3_suppl). 97–97. 1 indexed citations
5.
Shen, Chan, Christina E. Bailey, Lea Matsuoka, et al.. (2021). Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients. Cancer Medicine. 10(13). 4269–4281. 13 indexed citations
6.
7.
Yu, Evan Y., Josep M. Piulats, Gwénaëlle Gravis, et al.. (2020). 621P Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A update. Annals of Oncology. 31. S513–S514. 5 indexed citations
8.
Yu, Evan Y., Gwénaëlle Gravis, Brigitte Laguerre, et al.. (2020). Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A efficacy, safety, and biomarker results.. Journal of Clinical Oncology. 38(15_suppl). 5544–5544. 8 indexed citations
9.
Berry, William L., Peter C.C. Fong, Josep M. Piulats, et al.. (2020). KEYNOTE-365 cohort C updated results: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(6_suppl). 102–102. 15 indexed citations
10.
Yu, Evan Y., Peter C.C. Fong, Josep M. Piulats, et al.. (2020). PD16-12 PEMBROLIZUMAB PLUS ENZALUTAMIDE IN ABIRATERONE-PRETREATED PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: UPDATED RESULTS FROM KEYNOTE-365 COHORT C. The Journal of Urology. 203(Supplement 4). 6 indexed citations
11.
Kam, Audrey E. & Cathy Eng. (2020). Emerging role of immunotherapy in the treatment naïve metastatic colorectal cancer patient. 3. 87–87. 1 indexed citations
12.
Yu, Evan Y., Josep M. Piulats, Gwénaëlle Gravis, et al.. (2020). KEYNOTE-365 cohort A updated results: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(6_suppl). 100–100. 32 indexed citations
13.
14.
Kam, Audrey E., Sam G. Pappas, & Ashiq Masood. (2019). Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 27(5). 1314–1315. 1 indexed citations
15.
16.
Kam, Audrey E., Gopichand Pendurti, Umang Shah, et al.. (2018). Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials. Investigational New Drugs. 37(3). 490–497. 6 indexed citations
17.
Coté, Michele L., Audrey E. Kam, Leon Raskin, et al.. (2011). A Pilot Study of Microsatellite Instability and Endometrial Cancer Survival in White and African American Women. International Journal of Gynecological Pathology. 31(1). 66–72. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seung Tae Kim Breakdown of academic impact, for papers by L. Cannella Breakdown of academic impact, for papers by Markus Moehler Breakdown of academic impact, for papers by Jiaoyue Jin Breakdown of academic impact, for papers by Xiaobo Bo Breakdown of academic impact, for papers by Leonie K. de Klerk Breakdown of academic impact, for papers by Arnab Basu Breakdown of academic impact, for papers by Yunjian Huang Breakdown of academic impact, for papers by Juan Ruiz‐Bañobre Breakdown of academic impact, for papers by Sejung Park
Rankless by CCL
2026